Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid
- PMID: 2196812
- DOI: 10.1016/0002-9378(90)90590-4
Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid
Abstract
Oral contraceptives influence plasma proteins, causing changes in plasma procoagulants and fibrinolytic effectors. Estrogen is thought to be responsible for these changes, whereas progestogens, in particular those with an androgenic effect, may influence the magnitude of the changes. This concept is consistent with epidemiologic studies, suggesting a correlation between estrogen dose and cardiovascular episodes in oral contraceptive users. A delayed resolution of fibrin might contribute to an increased risk caused by decreased coagulation inhibition or fibrinolytic efficacy. Estrogen (30 micrograms or more) has a dose-dependent effect on clotting factors, including antithrombin III and proteins C and S. The effect of high- and low-dose oral contraceptives containing various progestogens on the fibrinolytic system is less clear. We have found that low-dose oral contraceptives containing levonorgestrel or lynestrenol enhance fibrinolysis, as revealed by an increase in plasminogen (30% to 40%), a decrease in histidine-rich glycoprotein (15% to 26%), an increase in tissue plasminogen activator activity (greater than 150%), and a decrease in tissue plasminogen activator inhibition (30% to 40%), concomitant with a slight decrease in tissue plasminogen activator antigen level (15% to 20%). New oral contraceptives contain less androgenic progestogens. Preliminary results of an ongoing study of women receiving either 20 micrograms of ethinyl estradiol with 150 micrograms of desogestrel or 30 micrograms of ethinyl estradiol plus 75 micrograms of gestodene revealed no change or changes similar to the older low-dose preparations after 6 months of treatment. Of particular importance was the finding that coagulation activation, expressed by the levels of thrombin-antithrombin III-complexes, fibrin formation, and the efficacy of fibrinolysis, expressed by the levels of fibrin degradation products, was identical in the two groups.
Similar articles
-
The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.Br J Obstet Gynaecol. 1996 Mar;103(3):261-7. doi: 10.1111/j.1471-0528.1996.tb09716.x. Br J Obstet Gynaecol. 1996. PMID: 8630312
-
Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.Am J Obstet Gynecol. 1993 Jan;168(1 Pt 1):32-8. doi: 10.1016/s0002-9378(12)90880-7. Am J Obstet Gynecol. 1993. PMID: 8420344 Clinical Trial.
-
A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.Contraception. 1996 Feb;53(2):75-84. doi: 10.1016/0010-7824(95)00271-5. Contraception. 1996. PMID: 8838483 Clinical Trial.
-
Haemostatic changes and the oral contraceptive pill.Baillieres Clin Obstet Gynaecol. 1997 Sep;11(3):545-64. doi: 10.1016/s0950-3552(97)80027-2. Baillieres Clin Obstet Gynaecol. 1997. PMID: 9488791 Review.
-
The effects on hemostasis of oral contraceptives containing desogestrel.Am J Obstet Gynecol. 1993 Mar;168(3 Pt 2):1047-52. doi: 10.1016/0002-9378(93)90336-h. Am J Obstet Gynecol. 1993. PMID: 8447359 Review.
Cited by
-
Ethinylestradiol/chlormadinone acetate.Drugs. 2004;64(7):751-60; discussion 761-2. doi: 10.2165/00003495-200464070-00005. Drugs. 2004. PMID: 15025547
-
Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations.Drugs. 1995 Aug;50(2):364-95. doi: 10.2165/00003495-199550020-00010. Drugs. 1995. PMID: 8521763 Review.
-
The progestin levonorgestrel induces endothelium-independent relaxation of rabbit jugular vein via inhibition of calcium entry and protein kinase C: role of cyclic AMP.Br J Pharmacol. 2000 Aug;130(8):1911-8. doi: 10.1038/sj.bjp.0703524. Br J Pharmacol. 2000. PMID: 10952682 Free PMC article.
-
Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.Ann Hematol. 1993 Jul;67(1):33-6. doi: 10.1007/BF01709663. Ann Hematol. 1993. PMID: 8392873
-
Hemostatic Factors and Ischemic Heart Disease Risk Among Postmenopausal Women.J Thromb Thrombolysis. 1995;1(2):125-131. doi: 10.1007/BF01062569. J Thromb Thrombolysis. 1995. PMID: 10603521
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources